Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mary P Panaccio"'
Autor:
Howard Busch, George J Wan, John Niewoehner, Parul Houston, Yujie Su, Cassie Clinton, Mary P Panaccio
Publikováno v:
Drugs in Context, Vol 11, Pp 1-12 (2022)
Introduction: Repository corticotropin injection (RCI, Acthar® Gel) is a naturally sourced mixture of adrenocorticotropic hormone analogues and other pituitary peptides with anti-inflammatory and immunomodulatory effects. In a recent clinical trial,
Externí odkaz:
https://doaj.org/article/eb31dceeb98b4a29b1148e7478374ec2
Publikováno v:
Journal of Health Economics and Outcomes Research (2022)
**Background:** Sarcoidosis, an inflammatory systemic granulomatous disease, affects multiple organs and has a diverse clinical course. Repository corticotropin injection (RCI) is an effective treatment for advanced symptomatic sarcoidosis. Since sar
Externí odkaz:
https://doaj.org/article/57fd2b3299684d278ea115927b9e7e73
Autor:
Roy Fleischmann, Kyle Hayes, Sung-Woo Ahn, George J. Wan, Mary P. Panaccio, Daniel Karlsson, Daniel E. Furst
Publikováno v:
Rheumatology and Therapy. 9:435-446
Autor:
George J. Wan, Bhavna Dhillon, Parul Houston, John Niewoehner, Mohammed Fahim, Mary P Panaccio, Kyle Hayes
Publikováno v:
Open Access Rheumatology : Research and Reviews
Kyle Hayes,1 Mary P Panaccio,1 Parul Houston,1 John Niewoehner,1 Mohammed Fahim,2 George J Wan,1 Bhavna Dhillon3 1Mallinckrodt Pharmaceuticals, Hampton, NJ, USA; 2KMK Consulting, Morristown, NJ, USA; 3United Rheumatology, Hauppauge, NY, USACorrespond
Autor:
Roman Bilyk, Mary P Panaccio, Enxu Zhao, Julie Zhu, Richard Furie, Anca Askanase, George J. Wan
Publikováno v:
Rheumatology and Therapy. 8:573-584
We conducted post hoc analyses of biomarker results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection (RCI; Acthar® Gel) in patients with persistently active systemic lupus erythematosus (SL
Publikováno v:
Rheumatology and Therapy
Repository corticotropin injection (RCI) is indicated as adjunctive, short-term therapy in selected patients with RA. To characterize RCI users and identify predictors of RCI initiation in RA, we compared preindex characteristics, treatment patterns,
Autor:
J. Bradford Rice, Emma Billmyer, Nathaniel Downes, Alan G. White, George J. Wan, John Niewoehner, Mark Simes, Mary P Panaccio
Publikováno v:
Current Medical Research and Opinion. 37:431-441
Repository corticotropin injection (RCI; Acthar Gel) is indicated to induce a diuresis or a remission of proteinuria in nephrotic syndrome (NS) without uremia of the idiopathic type or that due to lupus erythematosus. This study compares patient char
Autor:
Nathaniel Downes, J. Bradford Rice, John Niewoehner, George J. Wan, Alan G. White, Emma Billmyer, Mary P Panaccio, Mark Simes
Publikováno v:
Neurology and Therapy
Introduction Repository corticotropin injection (RCI; Acthar® Gel) is indicated for the treatment of acute exacerbations of multiple sclerosis (MS) in adults. Despite the well-documented clinical and economic benefits of RCI, many patients are denie
Publikováno v:
Advances in therapy. 39(7)
Repository corticotropin injection (RCI; ActharRheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are chronic autoimmune diseases. Clinical studies of drugs for these diseases do not often ask patients how they feel after treatment. Des
Autor:
Howard Busch, George J Wan, John Niewoehner, Parul Houston, Yujie Su, Cassie Clinton, Mary P Panaccio
Publikováno v:
Drugs in context. 11
Repository corticotropin injection (RCI, ActharPatients with RA who were prescribed RCI were identified through the ColumbusThe RCI cohort (These findings support the safety and effectiveness of RCI for short-term adjunctive treatment of refractory R